satellite symposium

SATELLITE
SYMPOSIUM
INVITATION
The European Accreditation Committee
in CNS (EACIC) has granted 2 CME
credits to this satellite symposium.
To obtain your CME credits, fill out the
evaluation form at www.eacic.eu
Treatment paradigms and importance of
outcome dimensions in schizophrenia
– patient and physician outlooks
Date: Sunday 18th September 2016
Time: 17:15–19:00
Venue: Hall F2
Moderator and Chairman: Jim van Os (The Netherlands)
Faculty: Peter Haddad (UK), Pierre-Michel Llorca (France),
Wolfgang Fleischhacker (Austria), Ofer Agid (Canada)
Satellite symposium on the occasion of the 29th ECNP Congress,
with educational financial support provided by Otsuka
Pharmaceutical Europe Ltd. and H. Lundbeck A/S
Date of preparation: June 2016. OPEL/0716/MTN/1603
XX-ABIM-2016.06-00007710
Treatment paradigms
and importance of
outcome dimensions in
schizophrenia – patient
and physician outlooks
AGENDA
17:15–17:25
Welcome; introduction to symposium format; set scene for Debate 1
Debate 1:
Jim van Os
(The Netherlands)
Managing schizophrenia: short-term benefit vs. long-term success 17:25–17:40
Short-term treatment outcome should be Peter Haddad
prioritised in schizophrenia(UK)
17:40–17:55
Long-term treatment outcome should be Pierre-Michel Llorca
prioritised in schizophrenia(France)
17:55–18:10
Summary and consensus Debate 2:
Jim van Os
(The Netherlands)
Managing schizophrenia: symptom control vs. improved functioning
18:10–18:15
Set scene for Debate 2 Jim van Os
(The Netherlands)
18:15–18:30
Symptomatic control should be prioritised Wolfgang Fleischhacker
in the treatment of schizophrenia(Austria)
18:30–18:45
Patient functioning and health-related Ofer Agid
quality of life (HRQoL) should be prioritised(Canada)
in the treatment of schizophrenia
18:45–19:00
Summary and consensus; closure Jim van Os
(The Netherlands)